Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MEmbranous Nephropathy Trial Of Rituximab (MENTOR)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Fernando Fervenza, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01180036
First received: August 10, 2010
Last updated: November 23, 2015
Last verified: October 2015